Pituitary adenylate cyclase-activating polypeptide (PACAP) is studied in laboratory research as a neuropeptide and as a tool in receptor-signaling and cell-culture studies in vitro. Laboratory work uses defined synthetic material so experiments are reproducible from lot to lot.
Structure: PACAP occurs in two amidated forms, PACAP-38 and the truncated PACAP-27, sharing the same N-terminal sequence, and form selection and sequence fidelity are key variables in laboratory studies comparing preparations in controlled systems. Identity and purity are confirmed by HPLC and mass spectrometry, and the lot-matched certificate of analysis is reviewed before use.
Laboratory applications: cell culture assays, receptor-binding studies comparing PACAP interactions with PAC1, VPAC1, and VPAC2 receptors in controlled in vitro systems, cyclic-AMP signaling assays in vitro, and stability studies under controlled laboratory conditions. Vehicle controls, analytical verification, and replication are standard. In vitro findings describe behavior in laboratory systems only; no conclusions about human use can be drawn from them.
Analytical notes: store lyophilized material sealed, protected from light and moisture; verify identity and purity by HPLC/MS on receipt; avoid repeated freeze-thaw cycles; record lot numbers in laboratory documentation.
Disclaimer: This material is supplied for laboratory research purposes only. Not for human consumption. Not for medical, therapeutic, diagnostic, or veterinary use. No dosing, reconstitution-for-use, or efficacy information is provided or implied.
Citations: standard PACAP and ADCYAP1 literature; PAC1/VPAC receptor characterization reviews; standard HPLC/MS methods.
